BioNeutra Global Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CAD 4.059 million compared to CAD 6.338 million a year ago. Net loss was CAD 26,583 compared to net income of CAD 168,538 a year ago. For the half year, sales was CAD 7.313 million compared to CAD 13.504 million a year ago. Net loss was CAD 1.416 million compared to CAD 956,328 a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.02 a year ago.